Breakthrough pancreatic cancer drug nearly doubles survival in trial - USA Today

Breakthrough pancreatic cancer drug nearly doubles survival in trial  USA TodayExperimental pill shows promise for advanced pancreatic cancer patients  WECTPromising News for Pancreatic Cancer  Cancer HealthASCO 2026 Ushers In a New Era for Pancreatic Cancer, Expands Targeted Therapy Options Across the GI Spectrum  OncLiveDaraxonrasib Extends Median Survival in Previously Treated Pancreatic Cancer  The ASCO Post